Complement-Based Drug Development Summit leaderboard
  • Friday, September 4, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 553

Author

Pharma Journalist 9038 posts 0 comments

Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million

Feb 4, 2020
Catalent and MaSTherCell Global announced that Catalent has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc. for an…
Read More...

Seqirus Announces FDA Approval of Its First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1)…

Feb 4, 2020
Seqirus announced that the U.S. Food and Drug Administration (FDA) has approved AUDENZ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) to help protect individuals six months of age…
Read More...

Emory, collaborators testing antiviral drug as potential treatment for coronaviruses

Feb 4, 2020
An antiviral compound discovered at Emory University could potentially be used to treat the new coronavirus associated with the outbreak in China and spreading around the globe. Drug…
Read More...

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE (rituximab)

Feb 3, 2020
Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing…
Read More...

CNS Pharmaceuticals Completes Pilot Manufacturing Steps Pursuant to FDA Pre-IND Guidance

Feb 3, 2020
CNS Pharmaceuticals announced that Anthem Biosciences of Bangalore, India (Anthem) has completed a pilot run of the recrystallization of the Reata Pharmaceuticals, Inc. API (Reata). It…
Read More...

Geneyork Pharmaceutical Announces U.S. Launch of Generic Version of Deltasone (Prednisone) Tablets

Feb 3, 2020
Geneyork Pharmaceutical, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, announced the U.S. launch…
Read More...

WPD Pharma Completed the Acquisition of Two Pancreatic Cancer Drug Candidates

Feb 3, 2020
WPD Pharmaceuticals Inc., a clinical stage pharmaceutical company, provides this update on the completed acquisition of exclusive sublicenses for two drug candidates from Moleculin…
Read More...

Vetter Aligns its Development Service Laboratory Portfolio Under One Roof

Jan 31, 2020
Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has brought together its development laboratories in one Ravensburg site end of last year. Designed…
Read More...

Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat

Jan 31, 2020
Johnson & Johnson announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as…
Read More...

Sandoz completes acquisition of Aspen’s Japanese operations

Jan 31, 2020
Sandoz announced that it has successfully completed the acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
  • Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
  • FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
  • Teva Discusses Lower Medicaid Drug Prices With Trump Administration
  • Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.